Login
Companies $ICUI
$182.24 +$2.97 (1.66%) Live
ICU MEDICAL INC logo

ICU MEDICAL INC

icumed.com

What Do They Do?

Sells infusion consumables, infusion pumps and related software, and critical-care products to hospitals, clinics, distributors and other healthcare providers.

How Do They Make Money?

Hospitals, distributors and other end customers generally pay for products, with most product sales paid within 30 days of delivery; the company sells most products when they ship. Software license renewals are paid at the start of each renewal period.

revenue
SegmentShareRevenue
Infusion Consumables
Sold outright

50%
FY2022: 43%
Infusion Systems
Mix

31%
FY2022: 27%
Vital Care
Sold outright

20%
FY2022: 30%

Who Are Their Customers?

Hospitals and other healthcare providers, along with medical product manufacturers, buy directly or through independent medical-supply distributors. Distributors also resell products to healthcare providers.

Customers above 10% of revenue, FY2025
of revenue from one customer
FY2024: 18% from one customer

Do Revenues Turn Into Profits?

Yes. It kept less than a cent of every revenue dollar as net income in FY2025 and turned 4 cents into free cash flow.

Operating income, FY2025
2% of revenue
▼ 0% vs FY2024 ($43M, 2%)
Net income, FY2025
0% of revenue
▲ Turned profitable vs FY2024 (−$117.7M, −5%)
Free cash flow, FY2025
4% of revenue
▼ −26% vs FY2024 ($124.7M, 5%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Revenue
▲ +4%
vs $537M in Q3 FY2025
Net income
▲ Turned profitable
vs −$3.4M in Q3 FY2025
Infusion Consumables share of revenue vs 53.1% in Q3 FY2025

Growing. Revenue grew 70% in 4 years, from $1.3B in FY2021 to $2.2B in FY2025, about 14% a year.

IV Solutions ownership and sales The older report described IV solutions as part of the company’s product portfolio. The latest report says it transferred the business to a joint venture, sold a controlling interest to OPF, and sells and distributes its products for the joint venture.

Integrated product portfolio The older report presented Smiths Medical products in separate sections while the company integrated that business. The latest report incorporates these products into its main product descriptions, including ambulatory and syringe pumps, vascular access, and vital care.

Revenue over time
Infusion Consumables Infusion Systems Vital Care
$2.5B$1.3B$0

Who Do They Compete With?

Competes with Becton Dickinson, Baxter International, B. Braun Medical, Angiodynamics, Teleflex, EquaShield, Medtronic, Moog Medical, Fresenius Kabi, Fresenius, Edwards Lifesciences, Belmont, Medical Technologies, and Intersurgical

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support